SPOTLIGHT: FDA approves Noxafil

The FDA has approved Noxafil, Schering-Plough's therapy for preventing fungal infections in leukemia patients. The infections-candida and aspergillus-are the leading cause of death among leukemia patients receiving chemotherapy or stem cell transplant therapies. Report